<DOC>
	<DOCNO>NCT00004479</DOCNO>
	<brief_summary>OBJECTIVES : Determine efficacy midodrine , selective alpha 1 adrenergic agonist , prevent neurally mediate syncope .</brief_summary>
	<brief_title>Randomized Study Midodrine , Alpha Adrenergic Agonist , Patients With Neurally Mediated Syncope</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind , crossover , placebo-controlled study . On day one , patient receive either midodrine placebo . On day three , patient receive opposite drug .</detailed_description>
	<mesh_term>Syncope</mesh_term>
	<mesh_term>Adrenergic Agonists</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis neurally mediate syncope ( vasovagal fainting ) Sudden fall blood pressure AND Slowing heart AND Temporary loss consciousness AND Hemodynamic response head tilt Prior/Concurrent Therapy No concurrent adrenergic agonist antiagonist Patient Characteristics Fertile patient must use effective birth control</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>syncope</keyword>
</DOC>